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Methionine (Met) is an amino acid essential for many impor-
tant cellular and biosynthetic functions, including the initiation
of protein synthesis and S-adenosylmethionine–mediated
methylation of proteins, RNA, and DNA. The de novo biosyn-
thetic pathway of Met is well conserved across prokaryotes but
absent from vertebrates,making it a plausible antimicrobial tar-
get. Using a systematic approach, we examined the essentiality
of de novomethionine biosynthesis in Salmonella enterica sero-
var Typhimurium, a bacterial pathogen causing significant gas-
trointestinal and systemic diseases in humans and agricultural
animals. Our data demonstrate that Met biosynthesis is essen-
tial for S. Typhimurium to grow in syntheticmediumandwithin
cultured epithelial cells where Met is depleted in the environ-
ment. During systemic infection of mice, the virulence of
S. Typhimurium was not affected when either de novoMet bio-
synthesis or high-affinity Met transport was disrupted alone,
but combined disruption in both led to severe in vivo growth
attenuation, demonstrating a functional redundancy between
denovobiosynthesis and acquisition as amechanismof sourcing
Met to support growth and virulence for S. Typhimurium dur-
ing infection. In addition, our LC-MS analysis revealed global
changes in themetabolome of S. Typhimuriummutants lacking
Met biosynthesis and also uncovered unexpected interactions
between Met and peptidoglycan biosynthesis. Together, this
study highlights the complexity of the interactions between a
single amino acid, Met, and other bacterial processes leading to
virulence in the host and indicates that disrupting the de novo
biosynthetic pathway alone is likely to be ineffective as an anti-
microbial therapy against S. Typhimurium.
Methionine (Met) is a sulfur-containing proteinogenic
amino acid that is required for the initiation of protein synthesis
(1). S-adenosylmethionine (SAM),7 a downstream derivative of
Met, acts as a major methyl donor in the cell and methylates a
variety of macromolecules, such as DNA, RNA, protein, and
lipids (2). A de novo pathway for Met biosynthesis is present in
the vast majority of prokaryotes, albeit with variations in the
enzymes that drive the biosynthetic cascade (3, 4). In contrast,
the full de novo Met biosynthesis is absent from vertebrates,
which must obtain this amino acid through external sources,
such as diet and gut flora (5, 6). In recent years, it has been
increasingly recognized that central metabolism represents a
promising yet underexploited area for the development of anti-
microbial drugs (7). The apparent essentiality in microbes and
absence in mammals makes the Met biosynthetic pathway an
especially attractive target for antimicrobial therapy.
Salmonella enterica is a Gram-negative, facultative intracel-
lular bacterium that causes gastrointestinal and systemic dis-
eases in animals and humans. There are2500 serovars in this
species, which include the human-adapted enteric fever patho-
gens S. enterica var. Typhi and Paratyphi, alongside non-ty-
phoidal Salmonella (NTS) serovars that cause debilitating gas-
troenteritis, including S. enterica var. Typhimurium (8, 9). For
all Salmonella serovars, the capacity to grow in the host is cen-
tral to bacterial virulence (10). In mammalian hosts, S. enterica
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grows in the blood and reticuloendothelial system largely
within a defined, membrane-bound endocytic compartment
called the Salmonella-containing vacuole (SCV) (11, 12). The
extent to which S. enterica salvages essential nutrients from the
lumen of the SCV and the nutrient composition of this vacuole
remains poorly defined, and the micronutrient environment of
the SCV has not been fully resolved. Ex vivo, S. enterica is capa-
ble of growth in minimal medium containing glucose as a car-
bon source and key ions, and the metabolic potential of this
species has been recognized and mapped (13). It is less clear,
however, how this considerable capability is exploited for max-
imal growth in vivo. The essentiality of the pathways can only be
determined by systematic analysis in vitro and in animal mod-
els, and fine mapping is required to determine whether essen-
tial pathways contain novel targets for antibiotic development.
The de novo biosynthetic pathway for Met has been previ-
ously reported in S. enterica (Fig. 1). This pathway is regulated
by the transcription factors MetJ and MetR (14). With its co-
repressor SAM, MetJ represses the transcription of all met
genes except metH (15). In contrast, MetR is an autoregulated
transcriptional activator that controls the expression of metA,
metF,metE, andmetH (16). In addition to de novo biosynthesis,
S. enterica is able to acquire Met from extracellular sources
through a high-affinity transporter that is encoded by themetD
locus, encoding an ATP-binding cassette (ABC) transporter
composed of three subunits: the ATPase (MetN), a transmem-
brane permease (MetI), and a periplasmicMet-binding protein
(MetQ). Biochemical analysis has shown that MetNIQ trans-
ports both the D- and L-enantiomers of Met (17, 18). In the
absence of the high-affinity MetNIQ transporter system,
genetic analysis has suggested that S. enterica is able to trans-
port Met at much lower affinity, through a putative and cryptic
low-affinityMet transporter system termed “MetP” (19–21). In
contrast toMetNIQ,MetP transports L-Met but not D-Met, and
the coding gene(s) for MetP remains unidentified to date.
S. entericamay encounter markedly different nutrient levels
during local (e.g. the gut) and systemic (e.g. the spleen and liver)
infections, which, in turn, may vary the bacterium’s depen-
dence on de novo biosynthesis and nutrient import pathways
for growth in different tissue niches. The enzymes required for
Met biosynthesis and theMet transporter have been implicated
in the virulence of S. enterica and other bacteria (22–28). How-
ever, these pathways have not been systematically investigated
for their role in the virulence of S. enterica. The aimof this study
was to investigate the essentiality of de novo biosynthesis and
transport of Met in the growth and virulence of S. Typhimu-
rium in vitro and in vivo.
Results
In vitro validation of theMet biosynthetic pathway in
S. Typhimurium and growth of definedMet auxotrophs in
mice
Previous transcriptional analyses of S. Typhimurium grown
in medium and in tissue culture cells have demonstrated that
the genes involved in the de novoMet synthesis pathway (metA,
metB,metC,metE,metF, andmetH) are expressed under a vari-
ety of growth conditions (Fig. S1; deduced from Ref. 29).
Whereas the expression level of the de novo pathway is rela-
tively low in rich medium, much stronger expression was
observed under growth conditions where the Salmonella path-
ogenicity island-2 (SPI-2) genes were expressed or when the
bacteria were inside macrophages (30).
Defined mutants in the Met biosynthetic pathway (metA,
metB, metC, metE, metF, metH, and metEmetH)
were generated in S. Typhimurium SL1344, sequenced, and
tested for their ability to grow in M9 minimal medium, with or
without added L-Met, and in nutrient-rich Luria–Bertani (LB)
medium. All mutants grew in LB medium at a rate comparable
with WT SL1344 (data not shown). In M9 minimal medium
supplemented with Met, Met mutants grew as efficiently as
SL1344 over a 24-h period (Fig. 2A), suggesting that the absence
of the de novo biosynthetic pathway was compensated by the
transport of exogenously available Met. As expected, the
metA, metB, metC, metE, and metF mutants exhibited
Met auxotrophy in M9 medium, whereas metH showed sub-
stantial growth over the 24-h period (Fig. 2A), confirming that
MetH is not essential for de novo biosynthesis of Met under
aerobic conditions (31, 32). The growth of themetHmutant in
M9mediumwas apparently supported by a functionalMet syn-
thase (i.e.MetE), asmetEmetH failed to grow inM9medium
in the absence of exogenousMet (Fig. 2A). It has been suggested
that the functionality of MetH in E. coli is vitamin B12–depen-
dent (33). To test whether there is an equivalent dependence in
S. Typhimurium, metE, metH, and metEmetH mutants
were grown in M9 medium with or without vitamin B12. All
threemutants grew in the presence of vitaminB12 (Fig. 2B). The
metE mutant, which depended on MetH to synthesize Met,
grew only when vitamin B12 was added (Fig. 2B), confirming
Figure 1. Schematic diagram of the biosynthetic pathway of Met in
S. Typhimurium. The first committed step of the pathway is catalyzed by
homoserine transsuccinylase (MetA), which succinylates homoserine to form
O-succinyl-L-homoserine, which then undergoes a condensation reaction
with cysteine to form L-cystathionine, catalyzed by cystathionine -synthase
(MetB). Cystathionine -lyase (MetC) catalyzes the conversion of L-cystathio-
nine to L-homocysteine, pyruvate, and ammonia. The final biosynthetic step
is catalyzed by distinct Met synthases, MetH and MetE, which are vitamin
B12-dependent and -independent synthases, respectively (31, 32, 64). In this
final step, L-homocysteine is condensed with 5,10-methyltetrahydrofolate
(CH3H4Folate), which donates themethyl group. 5,10-Methyltetrahydrofolate
is provided from the one-carbon cycle through amethylenetetrahydrofolate
reductase (MetF)-mediated reaction, producing tetrahydrofolate (H4Folate)
andMet (65). In S. enterica, Met is recycled through an activatedmethyl cycle.
The primary methyl donor, SAM, is formed by the activation of Met through
an ATP-dependent condensation reaction catalyzed by the SAM synthase
(MetK)(2, 66, 67). Catalytic enzymes are shown in red; arrows indicate the
direction of catalytic reactions.
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that MetH activity in S. Typhimurium is vitamin B12–depen-
dent. As S. Typhimurium synthesizes vitamin B12 only under
anaerobic conditions (31), growth of the metEmutant in M9
medium should have been restored when oxygen was depleted.
Indeed, metE, metH, and metEmetH both grew in M9
medium under anaerobic conditions and phenocopied their
growth in M9 medium with vitamin B12 under aerobic condi-
tions (Fig. 2C). These observations are consistent with an
understanding that S. Typhimurium synthesizes vitamin B12
under anaerobic conditions and support a level of functional
redundancy between MetE and MetH during de novo biosyn-
thesis of Met in S. Typhimurium.
To assess the requirement for de novo Met synthesis for
intracellular bacterial growth, HeLa cells were infected with
S. TyphimuriumWT and mutants, and the intracellular bacte-
rial load was assessed after 2, 5, and 10 h.WhenHeLa cells were
cultivated in DMEMgrowthmedium lackingMet, the intracel-
lular growth of metA, metB, metC, and metF was signifi-
Figure 2. The de novo biosynthetic mutants demonstrateMet-dependent growth inM9minimal medium and in HeLa cells but remain fully virulent
inmice. S. TyphimuriumWTSL1344 andmutant strainswere grown shaking at 37 °C inM9minimalmediumwith orwithoutMet (A), vitamin B12 (B), or oxygen
(C), and the number of viable bacteria (cfu) was determined after 24 h. Bars, mean cfu; error bars, data range.Dotted lines represent the bacterial concentration
at the time of inoculation. Data are pooled from two independent experiments. D, the de novo Met biosynthetic mutants become defective for intracellular
replication in HeLa cells whenMet is absent in the DMEM. HeLa cells were grown to amonolayer and infectedwith S. TyphimuriumWT ormutant strains at an
MOI of 5–10, inMet-freeDMEM. The intracellular bacterial load at 2hpost-infection is expressed as “1” andused as the referencepoint to calculate -fold change
of intracellular bacterial number at subsequent time points. Data are pooled from three independent experiments. Bars, mean cfu; error bars, data range.
Unpaired t tests were used to compare the intracellular load of WT andmutant strains at 10 h post-infection, and p values shown were corrected for multiple
comparisons using the Bonferroni–Dunn method; p values greater than 0.05 were deemed not significant (ns). For assessing virulence in vivo, age- and
sex-matchedC57BL/6micewere intravenously infectedwith 200 cfuof the indicated strains of S. Typhimurium, and thebacterial load in the liver (E) and spleen
(F) was determined at day 5 post-infection. Symbols represent data from individual animals, and horizontal lines represent the geometric mean of each group.
Data are pooled from two independent experiments. One-way ANOVAwith Bonferroni post-tests was used for statistical analyses comparing each pair of data
groups, and none of the comparisons yielded a p value 0.05.
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cantly attenuated comparedwith theWTcontrol (Fig. 2D). The
metE mutant only showed obvious growth after 5 h. In con-
trast, the metH mutant showed intracellular growth compa-
rable with SL1344, suggesting that a functional MetE is suffi-
cient for supporting intracellular replication in the SCV (Fig.
2D). Importantly, when HeLa cells were cultivated in DMEM
containing physiological levels of L-Met, none of the mutants
showed any significant defect in intracellular growth (Fig. S2),
demonstrating that exogenous Met can rescue Met auxotro-
phy, presumably reflecting direct or indirect transport of Met
from the culturemedium to the lumen of the bacteria-occupied
SCV.
Previous reports have proposed that Met biosynthesis might
be required for virulence of S. Typhimurium in mice or chick-
ens (24, 34). To test this requirement in mice, the virulence
of individual de novo biosynthetic mutants was studied in
C57BL/6mice, inwhichWTSL1344 is fully virulent and invari-
ably results in a systemic, lethal infection (35, 36). Groups of
mice were infected with 200 cfu of the different Met auxotro-
phic mutants intravenously, and, at day 5 post-infection, mice
were culled, and the bacterial load in the liver (Fig. 2E) and
spleen (Fig. 2F) was determined by viable count. The number of
bacteria recovered from mice infected with the mutants was
comparablewith those frommice infectedwith SL1344.Hence,
none of themutants showed virulence defects inmice following
intravenous infection. Another group of mice were infected
orally with metB, metE, metH, or metEmetH. The bac-
terial load in the spleen and liver of mice infected with the
mutant strains was comparable with those from mice infected
with theWT S. Typhimurium (Fig. S3). These data showed that
de novo Met biosynthesis is not essential for the growth of
S. Typhimurium in C57BL/6 mice, regardless of the route of
infection.
Met auxotrophs deficient in the high-affinity transporter
(MetNIQ) are attenuated inmice
Our observation that S. Typhimurium mutants were able to
grow intracellularly and in vivo without a functional de novo
Met biosynthetic pathway suggested that Met acquisition via
the transporters may play an important role in bacterial viru-
lence. To test this hypothesis, a high-affinity transporter
mutant of S. Typhimurium, metNIQ, was constructed. As
expected, themetNIQmutant grew inM9minimalmedium in
the absence of Met supplementation (Fig. 3A), suggesting that
the high-affinity Met transporter is not essential for growth in
M9 medium provided that de novo synthesis is intact.
To determine whether dual mutations in de novo biosynthe-
sis and the high-affinity transporter of Met affected the growth
of S. Typhimurium in vitro and in vivo, metNIQmetEH and
metNIQmetB mutants were generated. As expected, the
metNIQmetEH and metNIQmetB mutants were unable
to grow in M9 minimal medium without added Met (Fig. 3B);
this Met auxotrophy confirms that a combined deficiency in
both biosynthesis and high-affinity transport is inhibitive for
growth. Interestingly, the addition of L-Met into M9 medium
restored the growth of all of these mutant strains, consistent
with the presence and activity of the putative and functional
low-affinity transporter MetP (19, 20). Hence, these data sup-
port the theory thatMetP activity enables sufficientMet uptake
to facilitate efficient growth in vitro.
To determine whether the observed in vitro growth attenu-
ation was reflected by reduced growth of S. Typhimurium
inside mammalian cells, metNIQ, metNIQmetB, and
metNIQmetEH mutants were used to infect HeLa cells in
Met-free DMEM. Whereas metNIQ mutant was capable of
intracellular growth to a level similar to SL1344 over a 10-h
period, metNIQmetB and metNIQmetEH mutants were
unable to grow (Fig. 3C, top row). The presence of L-Met in
DMEM fully restored the growth of the mutant strains in HeLa
cells (Fig. 3C, bottom row), suggesting that the activity of the
cryptic transporterMetP was sufficient to support intracellular
growth in HeLa cells.
To determine whether dual mutations in de novo biosynthe-
sis and the high-affinity transporter of Met reduced S. Typhi-
murium virulence in vivo, C57BL/6 mice were intravenously
infected with metNIQ, metNIQmetB, and metNIQmetEH
mutant strains or WT. At day 5 post-infection, mice infected with
metNIQhad a similarly high bacterial load in the liver (Fig. 3D) and
spleen (Fig. 3E), comparablewith that of SL1344-infectedmice, indi-
cating that loss of the high-affinity Met transporter alone does not
reduce S.Typhimurium virulence in vivo. In contrast, infection with
metNIQmetBandmetNIQmetEHmutants resulted ina signif-
icantlyreducedbacterial loadintheliver(Fig.3D)andspleen(Fig.3E),
and this attenuationwas reversedwhen themetNIQmetBmutant
was complemented by metB (Fig. 3, D and E). Similar results were
obtainedwhen themetNIQmetB andmetNIQmetEHmutants
were used to infect mice via the oral route (Fig. S4), confirming that
metNIQmetB and metNIQmetEH are attenuated in mice
regardlessoftherouteof infection.Takentogether, theseresultsdem-
onstrate that restrictionofMet availabilityhas a strong impacton the
virulenceofS.Typhimurium in vivo, and thepresenceof theputative
cryptic transporter (MetP) alone is insufficient to sustain maximal
bacterial growth in the permissivemurine host.
Metabolite profiling in S. TyphimuriumMet biosynthetic and
high-affinity transporter mutants
To further define the impact of Met pathway gene disrup-
tions on bacterial metabolism, S. Typhimurium WT and
mutants lacking either or both of the de novo biosynthesis path-
way and the high-affinity Met transporter were grown in LB
medium, and polar metabolites were extracted and analyzed by
LC-MS. The intracellular accumulation of 5-methyl-tetrahy-
dropteroyltri-L-glutamate, a member of the polyglutamate
forms of 5-methyltetrahydrofolate (37), was significantly
increased in metH (10-fold) and further increased in
metNIQmetEH (25-fold), but not in metE, compared
with SL1344 (Fig. 4). This result suggests that both MetE and
MetH are functionally active, as S. Typhimurium grew in LB
broth, but MetH is either more abundant or more efficient in
the formation of 5-methyltetrahydrofolate. On the other hand,
the metB mutant exhibited a significantly elevated pool of
O-succinylhomoserine comparedwith theWT, consistent with
a defect in the MetB-catalyzed conversion ofO-succinylhomo-
serine to cystathionine (Fig. 4).
An untargeted mass/charge (m/z) feature analysis of the
mutant lines led to the identification of a number of unexpected
Methionine in Salmonella Typhimurium virulence
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Figure 3. S. Typhimurium mutants deficient in the de novo biosynthesis and high-affinity transport of Met are highly attenuated in mice. A and B,
S. Typhimurium strainswere grown shaking at 37 °C inM9minimalmediumwith orwithoutMet, and the number of viable bacteria (cfu) was determined after
24 h. Bars, mean cfu; error bars, data range.Dotted lines, bacterial concentration at the timeof inoculation. Data are pooled from two independent experiments.
C, HeLa cells were grown to a monolayer and infected with S. Typhimurium WT or mutant strains at an MOI of 5–10, in DMEM with or without Met. The
intracellular bacterial load at 2 h post-infection is expressed as “1” and used as the reference point to calculate -fold change of intracellular bacterial number at
subsequent time points. Bars, mean cfu; error bars, data range. Data are pooled from three independent experiments. Unpaired t tests were used to compare
the intracellular load ofWT andmutant strains at 10 h post-infection, and p values shownwere corrected formultiple comparisons using the Bonferroni–Dunn
method; p values 0.05 were deemed not significant (ns). For assessing virulence in vivo, age- and sex-matched C57BL/6 mice were intravenously infected
with 200 cfu of the indicated strains of S. Typhimurium, and the bacterial load in the liver (D) and spleen (E) was determined at day 5 post-infection.
metNIQmetB/pmetB-c denotes the complemented strainmetNIQmetB pACYC184metB. Symbols represent data from individual animals, and horizontal
lines represent the geometric mean of each group. Data are pooled from three independent experiments. One-way ANOVA with Bonferroni post-tests was
used for statistical analyses. ****, p 0.0001; ns, p 0.05.
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metabolite changes. Pairwise comparisons were performed to
identify differences that were statistically significant (p 0.05)
and to filter interesting m/z features. Deletion of metB led to
significant increases in the intracellular levels of SAM (5.5-fold
increase compared with WT), and a number of other metabo-
lites, including glycerate, adenine, hexose 6-phosphate, 3-phos-
phoglycerate, and gluconate, were also increased compared with
theWT(Fig. 5AandTable1).Bycomparison,metEdidnot show
Figure 4. Metabolite perturbations following genetic disruption toMet biosynthesis, one-carbon cycle, and activatedmethyl cycle. Total metabolite
pools in each strain were detected and quantitated using liquid chromatography-quadrupole TOF. Key intermediates of the Met biosynthetic pathway,
activated methyl cycle, and one-carbon cycle were identified and quantified for the indicated S. Typhimurium strains and compared with the WT level; -fold
changes are shown for 5-methyltetrahydropteroyltri-L-glutamate, amember of the polyglutamate forms of 5-methyltetrahydrofolate (A),O-succinylhomoser-
ine (B), Met (C), and SAM (D). metNIQmetB/pmetB-c denotes the complemented strain metNIQmetB pACYC184metB. Individual data points represent
biological replicates, and themean for each group is shown. One-way ANOVAs with Bonferroni post-tests were used to compare themetabolite level in each
mutant with WT; p values 0.05 are shown: *, p 0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001.
Methionine in Salmonella Typhimurium virulence
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any significantly differentm/z features (Fig. 5B), whereas only the
m/z feature corresponding to 5-methyl-tetrahydropteroyltri-L-
glutamate, a representative formof 5-methyltetrahydrofolate, was
significantly different in themetHmutant (Fig. 5C).
Interestingly, several m/z features corresponding to pepti-
doglycan biosynthetic intermediates were significantly differ-
ent for the metB mutant, including UDP-N-acetylmuram-
inate-alanine-glutamate (Fig. 5D). This, in turn, suggested an
Figure 5. Metabolite perturbations following genetic disruption tometB,metE, andmetH. Scatter plots depict WT compared withmetB (A),metE (B),
andmetH (C). Each dot represents a single extractedm/z feature with each axis depicting the arbitrary ion count.m/z features that are no different between
conditions plot along the diagonal. The color intensity indicates the confidence of the difference (greater intensity equates to lower variance across biological
replicates).Yellowhighlight, a subsetof confirmedmetaboliteswithastatistically significantdifference inapairwisecomparison (p0.05withBenjamini correction).
D, the levels of four metabolites associated with peptidoglycan synthesis were significantly altered in metB and metNIQmetB mutants. UDP-MurNAc, UDP-N-
acetylmuraminate;UDP-MurNAc-L-Ala,UDP-N-acetylmuramoyl-L-alanine;UDP-MurNAc-L-Ala-D-Glu,UDP-N-acetylmuramoyl-L-alanyl-D-glutamate;UDP-MurNAc-L-Ala-
-D-Glu-m-DAP, UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-diaminopimelate. metNIQmetB/pmetB-c, the complemented strain metNIQmetB
pACYC184metB. Individual data points represent biological replicates, and the mean for each group is shown. One-way ANOVAs with Bonferroni post-tests
were used to compare the metabolite level in each mutant with WT; p values0.05 are shown: *, p 0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001.
Methionine in Salmonella Typhimurium virulence
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association between Met biosynthesis and peptidoglycan bio-
synthesis. Disruption of metB led to a decrease in intracellular
concentrations of UDP-N-acetylmuraminate (0.4-fold) and a
large increase of UDP-N-acetylmuramoyl-L-alanine (12-fold),
UDP-N-acetylmuramoyl-L-alanyl-D-glutamate (1400-fold),
and UDP-N-acetylmuramoyl-L-alanyl-D--glutamyl-meso-2,6-
diaminopimelate (4-fold) (Fig. 5D). A decrease in UDP-N-
acetylmuraminate and an increase in UDP-N-acetylmuramoyl-
L-alanine (9-fold), UDP-N-acetylmuramoyl-L-alanyl-D-glutamate
(1000-fold), and UDP-N-acetylmuramoyl-L-alanyl-D--glu-
tamyl-meso-2,6-diaminopimelate (5-fold) was also observed in
the double mutant metNIQmetB (Fig. 5D).
Ex vivo, the metBmutant had a reduced growth rate com-
pared with the WT in bile salts. To study the impact of the
altered levels of peptidoglycan-related metabolites, the metB
mutant and WT were tested in LB broth in the presence of
EDTA, SDS, lysozyme, and fasted state–simulated intestinal
fluid, but no significant differences in growthwere found (Table
S1). A small increase (2mmon 15mm) in-lactam antibiotic
sensitivity, using a validated disc sensitivity method, was
observed for the metBmutant (data not shown). In addition,
when the metB and WT were tested in MacConkey broth
supplementedwith 0.6% bile salt, a small but consistent delay in
the growth of metB was observed (Fig. S5).
Discussion
There is increased interest in identifyingmetabolic pathways
in bacterial pathogens, which are essential and distinct from
those in their mammalian and human hosts, as potential anti-
biotic targets (38–42). Previous studies suggested that perhaps
400 S. enterica enzymes are dispensable and that essential path-
ways are often protected against random mutation by redun-
dancy, reflecting the selective pressure placed onmetabolism as
a key virulence trait (13). Met biosynthesis and transport is an
important part of the interconnected and interdependent
amino acid metabolism (43). In this study, the essentiality of
Met biosynthesis and transport in the mammalian virulence of
S. Typhimurium was investigated.
We showed that de novo Met biosynthesis is not essential
when the bacteria are able to obtain Met from their environ-
ment. The growth rate of the bacteria with or without de novo
Met biosynthesis appeared similar in Met-rich media (e.g. LB
broth), suggesting that transport systems can compensate for
the loss of de novo biosynthesis. Met biosynthetic mutants
require the presence of Met in the culture medium in order to
grow inside of HeLa cells (Fig. 2D and Fig. S2), suggesting that
extracellular Met becomes available to bacteria in the SCV
within a few hours of infection. It is likely that Met is relatively
abundant in the SCV during in vivo infection, as all of the Met
biosynthetic mutants were as virulent as WT S. Typhimurium
in mice (Fig. 2, E and F), presumably because the Met acquisi-
tion systems have access to a sufficient source of Met for sup-
porting bacterial growth in the infected animal.
It is only when de novo biosynthesis and high-affinity trans-
port of Met are both disrupted that we observed severe growth
attenuation in HeLa cells (Fig. 3C) and, importantly, in infected
mice (Fig. 3, D and E). This result strongly suggests functional
redundancy between transport and biosynthesis as a source
of Met for S. Typhimurium inside of the host. Whether Met
is acquired (e.g. metB) or synthesized (e.g. metNIQ and
metNIQmetB complemented withmetB), the growth in vivo
appears to be comparable, suggesting that either de novo bio-
synthesis or the high-affinity transport system ofMet alone can
provide Met in excess to what is required for S. Typhimurium
to grow at maximal capacity in the host. Hence, at least in the
case of S. Typhimurium, it is probably quite difficult to inhibit
growth by targeting the Met biosynthetic pathway. The obser-
vation that metNIQmetB and metNIQmetEH were still
able to grow in mice is suggestive of a Met acquisition system
independent of MetNIQ, which is consistent with the presence
of a low-affinity transporter MetP (19, 20). Hence, our study
Table 1
List of metabolites with significant changes inmetBmutant compared with WT
This table presents results from a one-way ANOVA performed with Tukey’s honestly significant difference tests (p 0.01). FDR, false discovery rate.
XCMS ID Metabolite name m/z
-Fold change
(metB to WT) p value FDR
M900T1200 4-Hydroxyphenylacetyl-CoA 900.15 3247.21 4.17E 07 4.01E 05
M878T1201 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate 878.17 1646.67 7.63E 08 1.45E 05
M880T1200 3-Hydroxyhexanoyl CoA 880.18 220.30 6.08E 07 5.15E 05
M749T1087 UDP-N-acetylmuramoyl-L-alanine 749.13 12.24 7.22E 06 2.49E 04
M163T480 Rhamnose 163.06 10.30 3.99E 08 1.33E 05
M275T1210 6-Phosphogluconate 275.02 8.93 1.01E 04 1.74E 03
M105T825 D-Glycerate 105.02 8.15 8.18E 06 2.67E 04
M259T1165 Hexose-phosphate 259.02 7.36 7.32E 04 8.43E 03
M266T579 Adenosine 266.09 6.13 1.44E 04 2.33E 03
M195T999 Gluconate 195.05 6.13 7.04E 07 5.68E 05
M1050T1225 UDP-N-acetylmuramoyl-L-alanyl-D--glutamyl-meso-
2,6- diaminopimelate
1050.26 5.63 1.75E 06 9.97E 05
M189T1246 Diaminoheptandioate 189.09 4.73 6.05E 07 5.15E 05
M620T1224 UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate 620.05 4.67 9.09E 09 7.57E 06
M134T607 Adenine 134.05 4.44 6.48E 06 2.31E 04
M686T707 Dephospho-CoA 686.14 4.22 1.36E 05 3.75E 04
M218T1006 O-Succinyl-L-homoserine 218.07 3.75 5.85E 05 1.14E 03
M145T567 2-Dehydropantoate 145.05 3.72 2.60E 05 6.15E 04
M130T567 Hydoxyproline 130.05 3.19 2.46E 04 3.57E 03
M273T1080 Succinyl-arginine 273.12 2.55 1.28E 04 2.11E 03
M678T1139 UDP-N-acetylmuraminate 678.09 2.45 1.41E 07 2.10E 05
M227T987 4-Phosphopantoate 227.03 2.11 3.55E 04 4.74E 03
M116T860 Valine 116.07 2.03 1.21E 04 2.02E 03
Methionine in Salmonella Typhimurium virulence
J. Biol. Chem. (2018) 293(24) 9506–9519 9513
 at U
niversity of Liverpool on Septem
ber 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
also provides additional support for the presence of a putative,
low-affinity transporter, MetP, which has yet to be identified.
Our description of this apparent redundancy between de
novo synthesis and high-affinity transport of Met conflicted
with previous studies that showed Met auxotrophs are defec-
tive for intracellular survival inmacrophages and epithelial cells
(22, 23) and have reduced virulence in mice (24, 28) and in
1-day-old chickens (34). This may be at least in part due to
differences in the study design. In our study, C57BL/6 mice
were infectedwith a single strain, whereas previous studies typ-
ically used competition assays (i.e. infecting the same host with
WT and mutant strains), which may put more pressure on the
mutant to grow in the competitive environment. It is not
uncommon to have divergent results from single infections and
competitive infections (44, 45). Another study has shown that
the S. Typhimurium lacking the high-affinity transporter Met-
NIQ is attenuated in C3H/HeN mice (25). C3H/HeN mice
carry the resistant allele ofNramp1, which controls Fe3 avail-
ability in the phagosome and is a major determinant of murine
susceptibility to S. Typhimurium; consequently, C3H/HeN
mice are much more resistant to S. Typhimurium infection
than theNramp1-deficient C57BL/6mice (46, 47). It is possible
that the differences in attenuation observed in earlier studies,
but not ours, relate to differences in genetic susceptibility of the
mice. Finally, earlier animal studies did not complement the
bacterial Met mutation nor sequence the mutant strains, and it
is possible that secondarymutations, notmutations inMet bio-
synthesis per se, were responsible for the observed attenuation
in mice.
To generate novel insights about the Met biosynthesis path-
way in S. Typhimurium, the changes in bacterial concentra-
tions of key metabolites were examined by LC-MS (Figs. 4 and
5). Mass spectrometry revealed substrate accumulation in Met
biosynthetic mutants metB, metE, metH, and the high-af-
finity transporter mutant metNIQ and mutants deficient in
both (metNIQmetB and metNIQmetEH). This analysis
revalidated the pathway model for Met biosynthesis shown in
Fig. 1, which has been proposed since the 1980s but to the
best of our knowledge, has not been systematically studied in
S. enterica until now.
The observed accumulation of substrates provides interest-
ing insights into the kinetics of enzyme activities. The deletion
of both Met synthases (i.e. metNIQmetEH) leads to a pro-
found difference in 5-methyltetrahydrofolate concentration, a
metabolite in the one-carbon cycle (Fig. 4). In the metH
mutant, there is a 10-fold higher intracellular concentration of
the substrate compared with metE, indicating that MetE is
much less efficient than MetH, supporting previous findings
(48). Presumably, perturbation of the one-carbon cycle led to an
accumulation of homocysteine, which is toxic for bacterial
cells (49, 50). This is probably why we consistently observed
that metNIQmetEH grew slower in vivo compared with
metNIQmetB (Fig. 3 and Fig. S4).
The disruption of the metB gene led to several unexpected
observations. First, the intracellular pool of SAMwas increased
in metB compared with WT (Fig. 4), indicating a defect in
SAMcatabolism following perturbation of the activatedmethyl
cycle in this mutant. This observation argues that in themetB
mutant, homocysteine, which is converted into SAM, cannot be
derived throughde novo biosynthesis inmetB and hence is not
fed into the activated methyl cycle. Further comparisons of the
LC-MS/MS data between metB and SL1344 revealed differ-
ences in many metabolites from disparate pathways; how
disruption to a single enzyme in Met biosynthesis caused
perturbations in other pathways was unclear, but the data dem-
onstrate the complexity of modeling intracellular metabolite
fluxes in bacteria. Interestingly, this analysis revealed that the
concentrations of several metabolites linked with peptido-
glycan synthesis were grossly increased in metB and
metNIQmetB (Fig. 5D). Enterobacteriaceae peptidoglycan
usually consists of alternating molecules of GlcNAc and
N-acetylmuramic acid that are linked by a tetrapeptide of L-al-
anine, D-glutamate, diaminopimelic acid (DAP), and D-alanine.
Because Met biosynthesis and m-DAP biosynthesis are linked
through aspartate metabolism (43) and L-cystathionine can
substitute for DAP (51), the perturbation of the intracellular
metabolite pools related toMet biosynthesis might also impact
peptidoglycan synthesis. Whereas LC-MS revealed significant
changes in the levels of peptidoglycan intermediates, these
changes were not reflected by increased sensitivity to agents
(e.g. -lactam antibiotics) that act through peptidoglycan syn-
thesis or directly onpeptidoglycanwith the exception of growth
in bile. Bile is known to remodel S. enterica peptidoglycan (52).
However, it is recognized that Enterobacteriaceae with altered
cell wall physiology are very robust. For example, E. coli with
decreasedm-DAP, which reduced the peptidoglycan density by
50%, did not show any detectable alteration in morphology or
growth characteristics (53).
The data obtained from the LC-MS analysis with the comple-
mented mutant metNIQmetB (Figs. 4 and 5) suggested that
complementation by pACYC184metB did not fully restore the
metabolite levels seen in the metNIQ mutant. However, this is
not unusual because, as related, genetic complementation using a
plasmidwill differ from the native level due to plasmid copy num-
ber and regulation, accounting for the partially complemented
phenomenon that is observed.
This study supports earlier models of S. entericametabolism
that have suggested significant redundancy in key pathways
linked with growth (13). The research reported here was a sys-
tematic analysis ofMetmetabolism in response to earlier inves-
tigations, which suggested that Met auxotrophy was attenuat-
ing for bacterial growth in animals and that de novo Met
metabolism might therefore provide new antibiotic targets.
The regulation ofMet synthesis, a complex regulon comprising
MetR andMetJ (16, 54), was not investigated because the aimof
the study was to determine the essentiality of de novoMet syn-
thesis in in vivo growth. We found that mutants unable to syn-
thesize Met efficiently obtained the amino acid from their
intracellular niche via their high-affinity Met transporter, sug-
gesting that the SCV contains sufficient Met to sustain normal
bacterial growth even in the absence of de novo synthesis.
Severe reductions in virulence in vivowere only observed when
both de novoMet biosynthesis and high-affinity Met transport
were lost. The impact of mutations in theMet biosynthesis and
transporter genes on other pathways was revealed, reaffirming
the complexity of the bacterial metabolome and the interac-
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tions between metabolites that have yet to be mapped. Consid-
erably more basic science on bacterial metabolism will be
needed to identify novel, functionally nonredundant targets.
Experimental procedures
Bacterial strains and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table 2. All mutant strains were constructed on the
S. Typhimurium SL1344 genetic background, and SL1344 was
used as theWT strain in all experiments. The SL1344 strain has
been described previously (36); its virulence is well defined and
is resistant to streptomycin. Appropriate antibiotics, including
streptomycin (50 g/ml), chloramphenicol (30 g/ml), kana-
mycin (50 g/ml), and ampicillin (100 g/ml), were added
to growth medium as required. To obtain mid-exponential
growth phase, S. Typhimurium and E. coli strains were grown
in 10 ml of LB broth (BD Difco) overnight, and 100 l of the
overnight culture was subcultured into 10 ml of fresh LB broth
and grown with shaking (180 rpm) at 37 °C for 3–4 h until the
optical density reading at 600 nm reached 0.6–0.8. Growth
phenotypes were characterized in LB broth or M9 minimal
medium (2 mM MgSO4, 0.1 mM CaCl2, 0.4% glucose, 8.5 mM
NaCl, 42 mM Na2HPO4, 22 mM KH2PO4, 18.6 mM NH4Cl, and
100M histidine). Met or vitamin B12 was supplemented at 100
M. For assessing growth under anaerobic conditions, cultures
were grown shaking in air-tight jars with AnaeroGen (Thermo-
Fisher) for depletion of oxygen.
Construction of strains and plasmids
Defined deletions of sequence encoding themet biosynthesis
genesmetA,metB,metC,metE,metF, andmetH andMet high-
affinity transportermetNIQwere generated in S. Typhimurium
SL1344. The biosynthetic mutant and high-affinity transporter
mutant were combined together to generate the doublemutant
metNIQmetB and the triple mutant metNIQmetEH.
ThedoublemutantmetNIQmetBwas complementedby intro-
ducing the de novo biosyntheticmetB gene into metNIQmetB
strain in trans. This strain is named metNIQmetB pACYC184
metB. Gene deletions and concomitant insertions of an antibi-
otic resistance cassette were constructed using a Lambda Red-
mediated “gene gorging” method (55). All constructs were ver-
ified by PCR and moved to an SL1344 or relevant background
via P22 phage transduction (36, 56). Primers used to construct
mutants are listed in Table 3. Genetic complementation of
mutant metNIQmetB was achieved by cloning metB into
pACYC184 via the BamHI and SalI sites and then introducing
pACYC184metB into the metNIQmetB mutant. All con-
structs were verified by restriction analysis and DNA sequenc-
ing. Key mutants were also sequenced using Illumina whole-
genome sequencing and analyzed using the pipeline at the
Wellcome Sanger Institute (Hinxton, UK).
Infection of epithelial cells
Infection of HeLa cells (sourced from American Type Cul-
ture Collection (ATCC)) was conducted using established gen-
tamicin protection assay protocols (57, 58). Briefly, HeLa cells
were grown in DMEM supplemented with 10% fetal calf serum
and 2 mM L-GlutaMAX (Life Technologies), in a humidified
37 °C, 5% CO2 incubator. One day before infection, HeLa cells
were seeded in 24-well plates at 2	 105 cells/well. S. Typhimu-
rium strains were grown to mid-exponential phase before and
were frozen in LB with 10% glycerol at 80 °C. Bacteria were
thawed immediately before infection, washed in antibiotic-free
tissue culture medium, and diluted in DMEM with or without
L-Met and then added to HeLa cell monolayers at a multiplicity
of infection (MOI) of 5–10. The cfu in the inoculum was esti-
mated by plating on LB agar plates. Infected HeLa cells were
centrifuged at 600	 g for 5 min immediately after the addition
of bacteria and then incubated for 1 h at 37 °C. After 1 h, the
tissue culture medium was replaced with DMEMwith or with-
out Met and containing 100 g/ml gentamicin to kill extracel-
lular bacteria. The concentration of gentamicin was reduced to
10 g/ml at 2 h post-infection and maintained for the remain-
der of the experiment. To enumerate intracellular bacteria,
cells were washed twice with PBS and lysed with 1% Triton
X-100 (Sigma) for 15 min to release the intracellular bacteria.
The bacteria were enumerated by plating appropriate dilutions
on LB agar plates.
Ethics statement
All animal research conducted in this study was approved by
the Animal Ethics Committee (Biochemistry and Molecular
Biology, Dental Science, Medicine, Microbiology, and Immu-
nology) at the University of Melbourne, under project number
1413141. All experiments were conducted in accordance with
theAustralianCode of Practice for theCare andUse ofAnimals
for Scientific Purposes, 8th edition, 2013.
Table 2
Strains and plasmids used for this study
Str, streptomycin; Ap, ampicillin; Chl, chloramphenicol; Km, kanamycin; Ara, arabinose; Flp, flippase; FRT, fippase recombinase target.
Strain or plasmid Relevant phenotypes and genotypes Source/Reference
Strains
S. enterica Typhimurium SL1344 Wild-type strain rpsL hisG46; StrR Ref. 36
S. enterica Typhimurium BRD666 Restriction negative modification positive (rm) SL1344; StrR Ref. 68
E. coli DH5 Cloning strain Ref. 69
Plasmids
pGEM-T Easy High-copy number cloning vector for PCR products; ApR Promega
pACBSR Medium-copy number, mutagenesis plasmid; p15A ori; Ara-inducible I-SceI and
 Red recombinase; ChlR
Ref. 55
pACYC184 Medium-copy number cloning vector, p15A ori; TetR, ChlR Ref. 70
pACYC184metB S. Typhimurium SL1344metB cloned into pACYC184; ChlR This study
pCP20 FLP recombinase, temperature-sensitive replicon; ApR, ChlR Ref. 71
pKD4 FRT-flanked KmR cassette; ApR, KmR Ref. 72
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Mouse infections
Age- and sex-matched C57BL/6 mice were used between 6
and 8 weeks of age to assess the virulence of mutant strains,
using either the intravenous or oral route of infection. For intra-
venous infections, 200 cfu of each bacterial strain was prepared
in 200 l of PBS and injected into the lateral tail vein. For oral
infections, mice were orally gavaged with 100l of 10% sodium
bicarbonate immediately before oral gavage of 200 l contain-
ing 5 	 107 cfu of S. Typhimurium strains. To prepare the
inoculum, all strains of S. Typhimuriumwere grown shaking at
180 rpm in M9 minimal medium supplemented with 100 M
Met, at 37 °C for 24 h, and stored in 10% glycerol at80 °C until
use. Immediately before infection, the stored aliquots were
thawed and diluted in PBS to the required concentration. At
designated time points post-infection, the spleen and liver were
removed aseptically, homogenated using the Stomacher 80
Biomaster paddle blender (Seward), and serial dilutions were
plated on LB agar plates with streptomycin to determine the
bacterial load.
Preparation of stock solutions and standards for LC-MS
Stock solutions of the related underivatizedmetabolites were
prepared at 1.0 mg/ml in an appropriate solvent. Before using,
the solutions were combined and diluted with water to give an
appropriate standard metabolite mix solution. 13C15N-Aspar-
tate (Cambridge Bioscience) was used as an internal standard
at 1 M in Milli-Q water. All stock solutions were stored at
20 °C.
Sample harvest (metabolic arrest) for LC-MS
Each S. Typhimurium strain was grown at 37 °C to mid-ex-
ponential phase in 10 ml of LB, with shaking at 180 rpm. The
culturewas diluted into 30ml of PBS and chilled in an ice/water
slurry for 5min and subsequently centrifuged (931	 g, 1 °C, 10
min). The pelletwas thenwashed in 1ml of PBS and centrifuged
(17,295	 g). This washing step was repeated before removing
the PBS and storing the cell pellet at 80 °C until metabolite
extraction was performed.
Extraction ofmetabolites for LC-MS
Cell pellets were resuspended with 400 l of 75% ethanol
solution containing 1:1000 of internal standard. Cell lysis was
ensured by repeated cycles of freeze-thaw, for a total of 10
times, while cooling to80 °C. Cellular debris was pelleted by
centrifugation (17,295 	 g, 5 min, 1 °C). The metabolic
extract was transferred to a new tube and stored at 80 °C
until analysis.
Instrumentation
A SeQuant ZIC-pHILIC column (5 M, 150	 4.6 mm; Mil-
lipore) coupled to a 1260 series HPLC system (Agilent) was
used to separate metabolites. The method used was
described previously (59) with slight modifications; a flow
rate of 0.3 ml/min with 20 mM ammonium carbonate in
water and 100% acetonitrile was used as the mobile phase. A
binary gradient was set up as follows: 0.5 min, 80% acetoni-
trile; 15.5 min, 50% acetonitrile; 17.5 min, 20% acetonitrile;
18.5 min, 5% acetonitrile; 21 min, 5% acetonitrile; 23 min,
80% acetonitrile; held at 80% acetonitrile until 29.5 min.
Detection of metabolites was performed on an Agilent
Q-TOF mass spectrometer 6545 operating in negative ESI
mode. The scan range was 85–1200 m/z between 2 and 28.2
min at 0.8 spectra/s.
Table 3
Oligonucleotide primers used in this study for construction of mutants and complementation
Endonuclease restriction sites are underlined; kanamycin resistance cassette-specific sequences are in boldace type. F, forward (5) primer; R, reverse (3) primer.
Mutants Sequence (5–3)
metA-ISceI-F TAGGGATAACAGGGTAATCGCCAGTGTTAACGCATGTTC
metA-ISceI-R TAGGGATAACAGGGTAATCGGAATACCACGAATCTGCC
metA-Kan-F CTAAGGAGGATATTCATATGCGCAGCCACGGTAATTTACTG
metA-Kan-R GAAGCAGCTCCAGCCTACACAACCTGATAACCTCACGACATACG
metB-ISceI-F TAGGGATAACAGGGTAATCGCAGATCGGCATCATCC
metB-ISceI-R TAGGGATAACAGGGTAATCTTCATCAACCTGCGGCTG
metB-Kan-F CTAAGGAGGATATTCATATGCGGTATTGAAGATGGCGAAG
metB-Kan-R GAAGCAGCTCCAGCCTACACACAGCCGTATTGTTCGTCATCG
metC-ISceI-F TAGGGATAACAGGGTAATCCTTCGTTATCTTCGCTGCC
metC-ISceI-R TAGGGATAACAGGGTAATCAGCAGAGTGCGGACAAACG
metC-Kan-F CTAAGGAGGATATTCATATGGCTGGTTCGGGTGCATATTG
metC-Kan-R GAAGCAGCTCCAGCCTACACACACTATTCACTGAGCCAAGCG
metE-ISceI-F TAGGGATAACAGGGTAATCTACCTGCGGCCAGCTTG
metE-ISceI-R TAGGGATAACAGGGTAATCAATGCGGTCGCCACTCTG
metE-Kan-F CTAAGGAGGATATTCATATGGGCGTTAGCGAACATGGTC
metE-Kan-R GAAGCAGCTCCAGCCTACACATCAACTCGCGACGCAGG
metF-ISceI-F TAGGGATAACAGGGTAATGCAGCCTGATGGAGCATGG
metF-SceI-R TAGGGATAACAGGGTAATGCCACGACCATCAATAGAACG
metF-Kan-F CTAAGGAGGATATTCATATGGCCGTGAAGGAGTGAAGGA
metF-Kan-R GAAGCAGCTCCAGCCTACACACTTCCGCCAGGCTCTGATTC
metH-ISceI-F TAGGGATAACAGGGTAATCGGTGAGTCGTGGAATTAGGC
metH-ISceI-R TAGGGATAACAGGGTAATCGTCAGGGCGACAAGATCC
metH-Kan-F CTAAGGAGGATATTCATATGGAGGATGTTGAGCGGTGGC
metH-Kan-R GAAGCAGCTCCAGCCTACACAGCCGTCCAGCACCAGAATAC
metNIQ-ISceI-F TAGGGATAACAGGGTAATCACAGCTGTGCAGCAGG
metNIQ-ISce-R TAGGGATAACAGGGTAATACTGCCCTGCGGATGG
metNIQ-Kan-F CTAAGGAGGATATTCATATGTCCCCTGCTGGAACACTT
metNIQ-Kan-R GAAGCAGCTCCAGCCTACACAGTCTGATGAAGTGTACGAAGCC
metB-BamHI-F TGGATCCGTCGCAGATGTGCGCTAATG
metB-SalI-R TGTCGACCATAATGCCTGCGACACGC
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Calibration and validation
LC-MS.d files were converted to .mzXML files using MS
convert and analyzed using the LCMS R package (60, 61). Fol-
lowing alignment, groups were extracted with a mass window
of 10 ppm, and statistical analysis was performed using Meta-
boAnalyst version 3.0 (62). The data set was uploaded, filtered
using the interquartile range, and log-transformed, and a one-
way ANOVA was performed with Tukey’s honestly significant
difference test (p 0.01). Data were analyzed usingMAVEN in
parallel to validate the LC-MS results (63). Following align-
ment, metabolites were assigned using exact mass (10 ppm)
and retention time (compared with a standards library of 150
compounds run the same day). Scatter plots were generated for
each pairwise comparison, and statistical significance was
determined using a p value 0.05 with Benjamini correction.
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SUPPLEMENTARY INFORMATION 
 
 
Methionine biosynthesis and transport are functionally redundant for the growth and virulence 
of Salmonella Typhimurium 
 
Asma Ul Husna1, Nancy Wang1*, Simon A. Cobbold2, Hayley J. Newton1, Dianna M. Hocking1, 
Jonathan J. Wilksch1, Timothy A. Scott1,3, Mark R. Davies1, Jay C. Hinton4, Jai J. Tree1,5, Trevor 
Lithgow6, Malcolm J. McConville2^, Richard A. Strugnell1* 
 
 
Materials included: 
 
Table S1: Survival analysis of S. Typhimurium wild-type and ΔmetB mutant in different types of 
media supplemented with a variety of substances for different times 
 
Supplementary Figure S1: Expression of genes in the de novo Met biosynthetic pathway of S. 
Typhimurium during stresses in relevant to in vivo infection 
 
Supplementary Figure S2: The presence of Met in tissue culture DMEM media restores the growth of 
mutants in the de novo Met biosynthesis pathway in HeLa cells 
 
Supplementary Figure S3: De novo Met biosynthetic mutants are not attenuated for oral infection in 
mice. 
 
Supplementary Figure S4: S. Typhimurium mutants with combined deficiency for biosynthesis and 
high-affinity transport of Met are attenuated for oral infection in mice. 
 
Supplementary Figure S5: S. Typhimurium ΔmetB mutant shows slower growth in high concentration 
of bile salt. 
 
 
 
 
 
 
 
 
 
 
 
  
S-2 
 
 
Table S1. Survival analysis of S. Typhimurium wild-type and ΔmetB mutant in different 
types of media supplemented with a variety of substances for different times. 
 
 
 
  
Different types of substances with different time-
point 
Difference in viable counts 
between wild-type and ΔmetB  
3.5% SDS, in LB, incubated for 2, 4, 6, 8 and 10 hours  No difference 
0.5 mM EDTA, in LB, for 2, 4, 6, 8 and 10 hours No difference 
3.5% SDS and 0.5 mM EDTA, in LB, for 2, 4, 6, 8 and 
10 hours 
No difference 
Different lysozyme concentration (0.5, 1, 2, 4, 8, 16 
mg/ml) in LB, incubated for 10, 20, 30, 40, 60, 80 and 
110 min after treatment with 0.5 mM EDTA  
No difference 
Different lysozyme concentration (0.5, 1, 2, 4, 8, 16 
mg/ml) in LB, incubated for 10, 20, 30, 40, 60, 80 and 
110 min after treatment with 1 mM EDTA 
No difference 
Distilled water for ten days No difference 
Fasted State Simulated Intestinal Fluid (FaSSIF) for 
seven days 
No difference 
S-3 
 
Figure legends 
 
Supplementary Figure S1. Expression of genes in the de novo Met biosynthetic pathway of S. 
Typhimurium during stresses in relevant to in vivo infection. Expression data were compiled from 
the SalComMac database (http://bioinf.gen.tcd.ie/cgi-bin/salcom.pl?db=salcom_mac_HL) as reported 
by Kröger et al (29) and Srikumar et al. (30), and provide detailed descriptions of media composition 
and stress. A) Absolute expression values for genes in the de novo Met biosynthetic pathway (transcripts 
per million). Growth conditions indicated below the heatmap are EEP (early exponential phase), MEP 
(mid exponential phase), LEP (late exponential phase), ESP (early stationary phase), LEP (late 
stationary phase), NonSPI2 (growth in PCN media (73) [pH 7.4 25mM Pi] to OD600 = 0.3), InSPI2 
(growth in PCN medium [pH 5.8, 0.4 mM Pi] to OD600 = 0.3), InSPI2 low Mg2+ (growth in PCN medium 
[InSPI2] with 10 mM MgSO4 to OD600 = 0.3), Intra-macrophages (infection of RAW264.7 macrophages 
for 8 hours, at a bacteria:macrophage ratio of 100:1). B) Relative expression (log2 fold change) of genes 
in the de novo Met biosynthetic pathway. Gene expression is shown relative to the first column in each 
block of samples (designated “normalizer”). Stress conditions are as described for absolute expression 
(A) and described in detail in (29). 
 
Supplementary Figure S2. The presence of Met in tissue culture DMEM media restores the 
growth of mutants in the de novo Met biosynthesis pathway in HeLa cells. HeLa cells were grown 
to a monolayer and infected with S. Typhimurium WT or mutant strains at a multiplicity of infection 
(MOI) of 5-10, in DMEM-complete media that contains 200 µM Met. The intracellular bacterial load 
at 2 hrs post-infection is expressed as “1” and used as the reference point to calculate fold-change of 
intracellular bacterial number at subsequent time points. Data are pooled from three independent 
experiments. Bars represent the mean cfu and error bars show the data range. Unpaired t-test was used 
to compare the intracellular load of WT and mutant strains at 10 hrs post-infection, and multiple 
comparisons were corrected using the Bonferroni-Dunn method; none of the comparisons yielded a p-
value below 0.05. 
 
Supplementary Figure S3. De novo Met biosynthetic mutants are not attenuated for oral infection 
in mice. C57BL/6 mice were oral gavaged with 10% sodium bicarbonate immediately before oral 
gavage with 5×107cfu of indicated strains of S. Typhimurium. The bacterial load in the A) liver and B) 
spleen were determined at day 6 post-infection. Symbols represent data from individual animals, and 
horizontal lines represent the geometric mean of each group. One-way ANOVA with Bonferroni post-
tests was used for statistical analyses comparing each pair of data groups, and none of the comparisons 
yielded a p-value below 0.05. 
 
Supplementary Figure S4. S. Typhimurium mutants with combined deficiency for biosynthesis 
and high-affinity transport of Met are attenuated for oral infection in mice. C57BL/6 mice were 
oral gavaged with 10% sodium bicarbonate immediately before oral gavage with 5×107cfu of indicated 
strains of S. Typhimurium. The bacterial load in the A) liver and B) spleen were determined at day 6 
post-infection. Symbols represent data from individual animals, and horizontal lines represent the 
geometric mean of each group. Data are pooled from three independent experiments. One-way ANOVA 
with Bonferroni post-tests was used for statistical analyses comparing each pair of data groups, and 
none of the comparisons yielded a p-value below 0.05. 
 
Supplementary Figure S5. S. Typhimurium ΔmetB mutant shows slower growth in high 
concentration of bile salt. The growth of S. Typhimurium wild-type and ΔmetB mutant was tested in 
MacConkey broth supplemented with 0.6% bile salt. Bars represent the mean optical density reading at 
600 nm (OD600) of three biological replicates for each strain, and error bars indicate the data range. 
Two-way ANOVA with Bonferroni’s multiple comparison test was used for statistical analyses, ***, 
p<0.001; ****, p< 0.0001; ns, p>0.05.  
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